Form 4 Tracker
Peter Scott Chin

Chief Medical Officer · 1 filing · Latest: Sep 4, 2026

Denali Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
DNLI
Peter Scott ChinChief Medical OfficerSep 4, 2026
Sale
$22.291,654$36.9K204,538
DNLI
Chin Peter Scott—Sep 4, 2026
Proposed Sale
$22.291,654$36.9K—